Comment Period Extended for the Drug Supply Chain Security Act (DSCSA) Proposed Rule: National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Provider

Receive this email as a forward? Subscribe to CDER SBIA industry updates. FDA | CDER | Small Business and Industry Assistance INDUSTRY NEWS . Comment Period Extended for the Drug Supply Chain Security Act (DSCSA) Proposed Rule: National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Provider FDA has extended the comment period for the Drug Supply Chain Security Act (DSCSA) proposed rule, "National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers" to September 6, 2022.  The proposed rule, when finalized, would establish national standards for the licensing of prescription drug wholesale distributors and third-party logistics providers. The rule would help ensure supply chain participants are sufficiently vetted and qualified to distribute prescription drugs, further strengthening the supply chain.   The agency believes that a 90-day extension allows adequate time for interested stakeholders to submit comments.  The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research  provides guidance, education and updates for regulated industry. Subscribe to CDER SBIA Email Updates Register for Upcoming Training View 2021 Recordings on YouTube Follow on LinkedIn Follow on Twitter This is an automated message delivery system. Replying to this message will not reach the CDER SBIA staff. If you have comments or questions, contact us at CDERSBIA@fda.hhs.gov or 1-866-405-5367 or (301) 796-6707.  SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA